| Identification | Back Directory |  [Name]
  BroMosporine |  [CAS]
  1619994-69-2 |  [Synonyms]
  BroMosporine N-[6-(3-Methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate ethyl 3-Methyl-6-(4-Methyl-3-(MethylsulfonaMido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-ylcarbaMate |  [Molecular Formula]
  C17H20N6O4S |  [MDL Number]
  MFCD26142669 |  [MOL File]
  1619994-69-2.mol |  [Molecular Weight]
  404.443 |  
 | Chemical Properties | Back Directory |  [density ]
  1.46±0.1 g/cm3(Predicted) |  [storage temp. ]
  2-8°C |  [solubility ]
  Soluble in DMSO (up to 25 mg/ml) |  [form ]
  solid |  [pka]
  6.21±0.46(Predicted) |  [color ]
  Off-white |  [Stability:]
  Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |  
 | Hazard Information | Back Directory |  [Description]
  Bromosporine (1619994-69-2) is a potent pan-Bromodomain (BRD) inhibitor.1?Bromosporine was able to reactivate HIV-1 replication in different latency models.2 |  [Uses]
  Bromosporine is a broad spectrum inhibitor for bromodomains. |  [in vivo]
 
 Bromosporine (100 mg/kg; i.p.; daily for 10 days) shows better antitumor activity than individual when co-treated with 5-Fluorouracil.html" class="link-product" target="_blank">5-FU (HY-90006)[1]. | Animal Model: | Female BALB/c nude mice (5-6 weeks; injected with 1?×?106?cells/100?μL of HT116?cells)[1] |  | Dosage: | 100 mg/kg |  | Administration: | i.p.; daily for 10 days |  | Result: | Exhibited better antitumor activity than individual Bromosporine or 5-FU (HY-90006) when co-treated with the two agent. |  
  |  [target]
  bromodomain |  [IC 50]
  HIV-1 |  [storage]
  Store at +4°C |  [References]
  1) Picaud?et al.?(2016),?Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia; Sci. Adv.?2?e1600760
2) Pan?et al.?(2017),?The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells; Oncotarget?8?94104 |  
  
             | 
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    
                        
                            | Company Name: | 
                            
                                BOC Sciences  
                             | 
                         
                        
                            | Tel: | 
                            1-631-485-4226; 16314854226 | 
                         
                        
                            | Website: | 
                            http://www.bocsci.com | 
                         
                    
                 
                
             |